The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: This study aimed to identify clinical features associated with premature mortality in a large contemporary cohort of adults with type 1 diabetes. RESEARCH DESIGN AND METHODS: The Finnish Diabetic Nephropathy (FinnDiane) study is a national multicenter prospective follow-up study of 4,201 adults with type 1 diabetes from 21 university and central hospitals, 33 district hospitals, and 26 primary health care centers across Finland. RESULTS: During a median 7 years of follow-up, there were 291 deaths (7%), 3.6-fold (95% CI 3.2–4.0) more than that observed in the age- and sex-matched general population. Excess mortality was only observed in individuals with chronic kidney disease. Individuals with normoalbuminuria showed no excess mortality beyond the general population (standardized mortality ratio [SMR] 0.8, 95% CI 0.5–1.1), independent of the duration of diabetes. The presence of microalbuminuria, macroalbuminuria, and end-stage kidney disease was associated with 2.8, 9.2, and 18.3 times higher SMR, respectively. The increase in mortality across each stage of albuminuria was equivalent to the risk conferred by preexisting macrovascular disease. In addition, the glomerular filtration rate was independently associated with mortality, such that individuals with impaired kidney function, as well as those demonstrating hyperfiltration, had an increased risk of death. CONCLUSIONS: An independent graded association was observed between the presence and severity of kidney disease and mortality in a large contemporary cohort of individuals with type 1 diabetes. These findings highlight the clinical and public health importance of chronic kidney disease and its prevention in the management of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic nephropathy, whether manifesting as microalbuminuria, macroalbuminuria, or a reduced glomerular filtration rate progressively augments the overall risk of macrovascular complications.118”
From Type 1 diabetes (2018) · cites this paper as [118]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, UACR is a continuous measurement, and differences within the normal and abnormal ranges are associated with kidney and cardiovascular outcomes (6,10,11).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [11]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“However, UACR is a continuous measurement, and differences within the normal and abnormal ranges are associated with kidney and cardiovascular outcomes (6,11,12).”
From 11. Chronic Kidney Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [12]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
Levey, A. S., Coresh, J., Bolton, K., Culleton, B. F., Harvey, K. S., Ikizler, T. A., Johnson, C. A., Kausz, A., Kimmel, P. L., Kusek, J. W., et al. (2002) · University of Groningen research database (University of Groningen / Centre for Information Technology) · Cited by 11,633
Proportional hazards tests and diagnostics based on weighted residuals
GRAMBSCH, P. M., & THERNEAU, T. M. (1994) · Biometrika · doi:10.1093/biomet/81.3.515 · Cited by 5,885 · cited 3×
“9* Any retinopathy 76 (29)† 1,313 (50) 420 (93)† 290 (99)† Retinopathy requiring laser therapy 27 (10)† 683 (25) 360 (78)† 288 (97)† Current smoker 98 (37)† 614 (24) 95 (22) 49 (16)† Established macrovascular disease 31 (11)† 123 (5) 116 (25)† 138 (47)† Macroalbuminuria 2 (3)† 210 (8) 338 (73)† N/A Microalbuminuria 2…”
MethodIntensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes
(2005) · New England Journal of Medicine · doi:10.1056/nejmoa052187 · Cited by 5,138
Goodpasture syndrome during the course of a Schönlein-Henoch purpura
Carreras, L., Poveda, R., Bas, J., Mestre, M., Rama, I., & Carrera, M. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32799 · Cited by 1,474
Albuminuria reflects widespread vascular damage: The Steno hypothesis
Deckert, T., Feldt-Rasmussen, B., Borch-Johnsen, K., Jensen, T., & Kofoed-Enevoldsen, A. (1989) · Diabetologia · doi:10.1007/bf00285287 · Cited by 1,400
Doqi, K. (2002) · American Journal of Kidney Diseases · Cited by 1,285
Global guideline for type 2 diabetes
(2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.10.001 · Cited by 1,064
Conditioning Diagnostics: Collinearity and Weak Data in Regression
Goldstein, R. (1993) · Technometrics · doi:10.1080/00401706.1993.10484997 · Cited by 911
(2004) · doi:10.1177/0049124103262065 · Cited by 906
Cited by
Items 501–600 of 651
Treatment Goals in Diabetic Nephropathy
Vervoort, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-93521-8_25 · Cited by 2
Kidney disease in diabetology: lessons from 2009
Schernthaner, G.-H. (2010) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp759 · Cited by 2
“Recent findings [5] from the Finnish Diabetic Nephropathy (FinnDiane) study clearly demonstrate that chronic kidney disease (CKD) is the dominant contributor to this excess mortality.”
ResultPreparation of the dialysis patient with type 1 diabetes mellitus for kidney transplantation
Martynov, S. A., Severina, A. S., Larina, I. M., Shamhalova, M., Арзуманов, С. В., Пинчук, А. В., & Shestakova, M. V. (2020) · Problems of Endocrinology · doi:10.14341/probl12686 · Cited by 2
Marcel, S., Abid, A., Vesa, C. M., Aron, R. A. C., Ghitea, T. C., Angelescu, G. A., & Popa, A. R. (2021) · Archives of the Balkan Medical Union · doi:10.31688/abmu.2021.56.1.12 · Cited by 2
Role of lipopolysaccharide in genesis of microvascular complications in type 1 diabetes mellitus
Beloglazov, V. A., Yatskov, I. A., & Ulyanova, D. I. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-rol-2863 · Cited by 2
Psychological determinants and self care in patients with type 1 diabetes
Ahola, A. J. (2012) · Helda - University of Helsinki Institutional Repository · Cited by 3
Azar, M., Coirier, É., Delyfer, M., Korobelnik, J., Mohammedi, K., Blanco, L., Alexandre, L., Monlun, M., & Rigalleau, V. (2018) · Diabetes Care · doi:10.2337/dc18-0510 · Cited by 2
Moutairou, A., & Roussel, R. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30261-3 · Cited by 1
Johnson, K. A., Nyankima, A. G., Dayton, P. A., & Chang, E. (2016) · IEEE International Ultrasonics Symposium · doi:10.1109/ultsym.2016.7728850 · Cited by 1
Stratigou, T., Vallianou, N. G., Koutroumpi, S., Vlassopoulou, B., Apostolou, T., Tsagarakis, S., & Ioannidis, G. (2019) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-0848-8076 · Cited by 1
Cheng, Y., Xu, C., Wang, S., Hou, L., Guan, Q., & Zhou, X. (2020) · Minerva Endocrinology · doi:10.23736/s0391-1977.20.03147-8 · Cited by 1
Yu, T. T., Mukuba, D., Casabar, M., Byrne, C., Shlomowitz, A., Jacob, P., Huda, M. S. B., Yaqoob, M. M., & Chowdhury, T. A. (2025) · Diabetic Medicine · doi:10.1111/dme.70075 · Cited by 1
Characteristics of above 65-year-olds with type 1 diabetes in the Finnish diabetic nephropathy study
Franzén, E. M., Eriksson, M., Satuli-Autere, S., Ylinen, A., Sigfrids, F. J., Nicklén, J., Öhman, H., Groop, P., & Thorn, L. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02613-0 · Cited by 1
“%) died, and of these deaths 226 (73,1) were due DKD was also clearly less common in the above 65-year-olds, suggesting that the high mortality rates related to DKD [2] translates into increased likelihood of reaching older age in those without kidney disease.”
Self-citationVessari, H., Prami, T., Peltonen, E. J., Pimiä, E., Iso-Mustajärvi, I., Kalaoja, M., Luoto, H., Vauhkonen, I., & Saukkonen, T. (2026) · Diabetes, obesity and metabolism · doi:10.1111/dom.70641
“Albuminuria and reduced eGFR are both strong risk factors for cardiovascular morbidity and mortality in individuals with T1D [30].”
Ferreira-Divino, L. F., Poulsen, C., Curovic, V. R., Urbak, L., Collet-Billon, A., Rouet, L., Frimodt‐Møller, M., Eldrup, N., Hansen, T. W., Sillesen, H. H., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70695 · Cited by 1
“The median [IQR] TPV across historic categories of albuminuria in type 1 diabetes were: normal-17 [0–127] mm 3 , moderately increased-26 [0–141] mm 3 and severely increased-72 [6–200] mm 3 .”
Genetic Risk Factors for Kidney Function in Individuals with Type 1 Diabetes
Limonte, C. P., Gao, X., Roshandel, D., Bebu, I., Karger, A. B., Lorenzi, G. M., de Boer, I. H., Perkins, B. A., & Paterson, A. D. (2026) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.0000001111 · Cited by 1
Histomorphologie und Pathogenese der diabetischen Nephropathie
Amann, K., & Daniel, C. (2020) · Der Nephrologe · doi:10.1007/s11560-020-00407-9 · Cited by 1
Pichler, R. H., de Boer, I. H., Diaz, M. F. P., & Afkarian, M. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4454-1_45 · Cited by 1
Renal dysfunction in patients with myocardial infarction concurrent with type 2 diabetes mellitus
Evseeva, М. V., Каретникова, В. Н., & Барбараш, О. Л. (2015) · Terapevticheskii arkhiv · doi:10.17116/terarkh2015871105-108 · Cited by 2
Microvascular and Macrovascular Complications in Children and Adolescents with Type 1 Diabetes
Chiarelli, F., & Marcovecchio, M. L. (2011) · InTech eBooks · doi:10.5772/22029 · Cited by 1
“Similarly, Orchard et al. reported a standardized mortality ratio of 6.4, 12.5 and 29.8 for individuals with microalbuminuria, proteinuria and ESRD, respectively, in a cohort with childhood-onset type 1 diabetes followed longitudinally for 30 years (Orchard et al., 2010).”
BackgroundInfluentialRenal Transplantation in Type 1 Diabetes Mellitus: An Unusual Case Report
Guerra, J. O., Melo, M. J., Gonçalves, J. A. F., Nascimento, C. D. M. C., Santana, A., & da Costa, A. G. (2015) · Transplantation Proceedings · doi:10.1016/j.transproceed.2015.03.032 · Cited by 1
Screening, Early Diagnosis, Genetic Markers, and Predictors of Diabetic Nephropathy
Cohen, E. P., & Krzesinski, J.-M. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_7 · Cited by 1
Trevor Orchard: Fruitful Contributions to Diabetes Epidemiology
Adler, A. (2015) · Diabetes Care · doi:10.2337/dc15-0159 · Cited by 1
The Prognosis of Patients with Chronic Kidney Disease and Diabetes Mellitus
Vladu, I. M., Clenciu, D., Bîcu, M. L., & Mofa, M. (2014) · Romanian Journal of Diabetes Nutrition and Metabolic Diseases · doi:10.2478/rjdnmd-2014-0025 · Cited by 1
“The presence and severity of CKD is a predictor for all-cause mortality in type 1 diabetes mellitus (T1DM) [3].”
BackgroundImproved Early Risk Stratification With Cystatin C–Based Estimated GFR
Pavkov, M. E., & Nelson, R. G. (2014) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2014.02.006 · Cited by 1
Evaluating cardio‐renal protection for adolescents with type 1 diabetes: the current AdDIT trial
Marcovecchio, M. L., & Dunger, D. B. (2012) · Practical Diabetes · doi:10.1002/pdi.1684 · Cited by 1
Lipoproteins and Diabetic Nephropathy
Mäkinen, V., Tolonen, N., & Groop, P. (2013) · Contemporary diabetes · doi:10.1007/978-1-4614-7554-5_14 · Cited by 1
Self-citationNeves, M. D. F. (2013) · Journal of Diabetes & Metabolism · doi:10.4172/2155-6156.s9-002 · Cited by 1
Medical Family Therapy in Endocrinology
Zubatsky, M., & Mendenhall, T. J. (2018) · Focused issues in family therapy · doi:10.1007/978-3-319-68834-3_11 · Cited by 1
Heller, T., Kloos, C., Lehmann, T., Schiel, R., Lorkowski, S., Wolf, G., Müller, U. A., & Muller, N. (2018) · Diabetologie und Stoffwechsel · doi:10.1055/s-0044-102046 · Cited by 1
Al-Nori, M. K. J., & Ahmed, A. J. (2019) · Al-Mağallaẗ al-ʻirāqiyyaẗ li-l-ṣaydalaẗ · doi:10.33899/iphr.2019.0161197 · Cited by 1
Rawshani, A., Rawshani, A., Sattar, N. A., Franzen, S., McGuire, D. K., Eliasson, B., Svensson, A., Zethelius, B., Miftaraj, M., Rosengren, A., et al. (2019) · Yearbook of pediatric endocrinology · doi:10.1530/ey.16.10.17 · Cited by 1
Pancreatic Transplantation in Diabetes: Indications, Contraindications and Perspectives
Rocha‐Santos, V., & Pantanali, C. A. R. (2020) · Springer eBooks · doi:10.1007/978-3-030-53370-0_49 · Cited by 1
Diabetic Nephropathy in Children
Marcovecchio, M. L., & Chiarelli, F. (2014) · Springer eBooks · doi:10.1007/978-3-642-27843-3_45-1 · Cited by 1
Setti, M. O., Kacimi, S. E. O., NISKANEN, L. K., Virtanen, J. K., & Tuomainen, T. (2022) · Journal of Renal Nutrition · doi:10.1053/j.jrn.2022.01.009 · Cited by 1
Marshall, S. M., & Flyvbjerg, A. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch39 · Cited by 1
Ambler, G. R., Cameron, F. J., Joshi, K., & Wherrett, D. K. (2019) · Wiley eBooks · doi:10.1002/9781119152712.ch15 · Cited by 1
Diabetic Kidney Disease: Identification, Prevention, and Treatment
Caramori, M. L., & Rossing, P. R. (2022) · Springer eBooks · doi:10.1007/978-3-030-98927-9_7 · Cited by 1
Diabetic Nephropathy in Type 1 Diabetes Mellitus
Rossing, P. R. (2022) · Updates in hypertension and cardiovascular protection · doi:10.1007/978-3-031-13009-0_15 · Cited by 1
Lerner, G. (2025) · Kidney360 · doi:10.34067/kid.0000000664 · Cited by 1
Frequency of albuminuria in diabetic patients presenting with macrovascular complications.
Sohail, M., Fatima, F., Fatima, S., Khan, S. A., Anwar, S. A., Alam, M. A., & Abbasi, M. A. (2014) · PubMed · Cited by 1
Insulin Resistance and the Kidney in Youth
Bjornstad, P., & Cherney, D. Z. I. (2019) · Contemporary Endocrinology · doi:10.1007/978-3-030-25057-7_14 · Cited by 1
Can lipid abnormalities predict renal disease in patients with diabetes?
Tolonen, N., & Groop, P. (2010) · Clinical Lipidology · doi:10.2217/clp.10.1 · Cited by 1
Self-citationOutcome of Ischaemic Foot Ulcers in Patients with Diabetes, with or without Revascularization
Elgzyri, T. (2014) · Lund University Publications (Lund University) · Cited by 1
Cardiovascular Disease in Diabetic Nephropathy
Hamm, L. L., Thethi, T. K., & Hering-Smith, K. S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0793-9_11
Early autonomic dysfunction in type 1 diabetes : Insights into its significance and mechanisms
Rosengård‐Bärlund, M. (2014) · Helda - University of Helsinki Institutional Repository
Self-citationTofik, R. (2014) · Lund University Publications (Lund University)
Physical activity and diabetic complications in patients with type 1 diabetes
Wadén, J. (2010) · Helda - University of Helsinki Institutional Repository · Cited by 2
Self-citationRenoprotective Effects of C-Peptide on Type 1 Diabetes
Nordquist, L., Kallas, Å., Stridh, S., Palm, F., & Wahren, J. (2011) · Humana Press eBooks · doi:10.1007/978-1-61779-391-2_7
Medication among patients with type 1 diabetes and predialytic renal disease
Helve, J., Sund, R., Haapio, M., Groop, P., Grönhagen‐Riska, C., & Finne, P. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.12.010
“diabetes and end-stage renal disease (ESRD) have an 18-fold mortality [1].”
BackgroundSelf-citationEighty years on insulin and ‘going strong’
White, R., Stirling, A., White, S., & Collier, A. (2014) · Practical Diabetes · doi:10.1002/pdi.1870
Diabetic kidney disease: new treatment options
Thomas, M. C. (2013) · Diabetes Management · doi:10.2217/dmt.13.3
Self-citationBiomarkers for evaluating renal function decline in diabetes: where are we now?
Snell‐Bergeon, J. K. (2012) · Diabetes Management · doi:10.2217/dmt.12.50
EnRAGEd about death in type 1 diabetes
Orchard, T. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2229-y
“This link between renal mortality and total mortality has recently been further highlighted by the Finnish Diabetic Nephropathy (FinnDiane) study group, which has reported that all the excess mortality over a 7-year period of follow-up of type 1 diabetes in Finland is seen in those who develop microalbuminuria and mor…”
ResultMarcovecchio, M. L., & Dunger, D. B. (2014) · Diabetes Management · doi:10.2217/dmt.14.8
Importance of reno-protection in adolescents with diabetes and microalbuminuria
Marcovecchio, M. L., & Dunger, D. B. (2011) · Diabetes Management · doi:10.2217/dmt.11.43
Regulation of Podocyte apoptosis in Diabetic Kidney Disease - Role of SHIP2, PDK1 and CDK2
Saurus, P. (2016) · Helda - University of Helsinki Institutional Repository
Genetics of Diabetic Micro- and Macrovascular Complications
Sandholm, N., Groop, P., & Doria, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-01574-3_7
Self-citationHar, R. L. H. (2014) · TSpace (University of Toronto)
Adolescent Prevention of Complications
Marcovecchio, M. L., & Dunger, D. B. (2016) · Springer eBooks · doi:10.1007/978-3-319-40242-0_4
Davey, R. J. (2010) · UWA Profiles and Research Repository (UWA)
Fu, H. (2017) · D-Scholarship@Pitt (University of Pittsburgh)
Increased urinary albumin excretion in children with type 1 diabetes: is it a reason for concern?
Costacou, T. (2018) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.03.005
Genetics of Diabetes and Diabetic Complications
Prasad, R. B., Ahlqvist, E., & Groop, L. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_6-1
AbuShady, M. M., Fathy, G. A., El-Alameey, I. R., Ma, A., Galal, E. M., & Atef, S. N. (2018) · Asian Journal of Pharmaceutical and Clinical Research · doi:10.22159/ajpcr.2018.v11i5.23518
Fries, C. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0343-x
Bujang, M. A., Tiong, X. T., Sapri, F. E., Ismail, M., Mustafa, F. I., & Hamid, A. M. A. (2018) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-018-0686-2 · Cited by 1
You, Z. (2017) · KU ScholarWorks (University of Kansas)
Application of Various Equations for Estimating GFR in Patients with Type 1 Diabetes
Kaplanian, M. V., Hodzhayan, A. B., Gevandova, M. G., Elbekyan, K., Kaplanova, E. V., & Амлаев, К. Р. (2020) · American Journal of Internal Medicine · doi:10.11648/j.ajim.20200802.15
Microvascular Disease and Chronic Kidney Disease in Persons With Diabetes in Grenada
Lewis, J. E. (2020) · ScholarWorks (Walden University)
Diabetic Kidney Disease and Cardiovascular Disease
Muta, K., Obata, Y., & Nishino, T. (2020) · Springer eBooks · doi:10.1007/978-981-15-9301-7_3 · Cited by 1
Marcovecchio, M. L., & Papadopoulou‐Marketou, N. (2021) · Springer eBooks · doi:10.1007/978-3-642-27843-3_102-1
Enriquecimento da HDL em apolipoproteína A-IV favorece sua funcionalidade na doença renal diabética
Santana, M. D. F. M. (2020) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.5.2020.tde-10022021-101317
Nicholl, D. D. M., Whitelaw, J. P., Weir, R. V., Bissonnette, M. L. Z., Gill, J. S., & Landsberg, D. N. (2021) · Transplantation Direct · doi:10.1097/txd.0000000000001240
Current literature in diabetes
(2010) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1015
High Frequency of Nephropathy Among the Iranian Children and Adolescents With Type 1 Diabetes
Arad, B., Chegini, V., Talati, N., Homaei, A., & Saffari, F. (2021) · The Journal of Qazvin University of Medical Sciences · doi:10.32598/jqums.25.2.1077.3
Type 1 Diabetes: Clinical and Experimental
Marcovecchio, L., & Chiarelli, F. (2013) · Yearbook of pediatric endocrinology · doi:10.1159/000353836
Cancho, B., Robles, N. R., Félix-Redondo, F. J., Lozano, L., & Fernandez-Berges, D. J. (2021) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2020.10.019
Application of Various Equations for Estimating GFR in Patients with Type 1 Diabetes
Kaplanian, M. V., Hodzhayan, A. B., Gevandova, M. G., Elbekyan, K., Kaplanova, E. V., & Амлаев, К. Р. (2020) · Advanced Biomedicine · doi:10.54730/abm.2020.020205
Gopi, K., Nigoskar, S., Vaitla, P., Meenakshi, G., & Haindavi, H. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns4.11237
Activation of renal dopaminergic system in early diabetic nephropathyPreprint
Horita, S., Watanabe, G., Misaka, S., Taira, S., Satoh, M., Maejima, Y., Shimomura, K., Kazama, J. J., & SHIGETOMI, S. (2022) · Research Square · doi:10.21203/rs.3.rs-1939167/v1
Cardiovascular outcome according to renal status in Finnish patients with type 2 diabetes
Hellman, T., Skare, O.-C., Lee, C., Wagner, U., Vikkula, J., Hällfors, J., Laatikainen, O., Lassenius, M. I., & Metsarinne, K. P. (2022) · Diabetes Epidemiology and Management · doi:10.1016/j.deman.2022.100103
Marcovecchio, M. L., & Papadopoulou‐Marketou, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-52719-8_102
USO DE PRECEDEX NA VENTILAÇÃO NÃO INVASIVA PEDIÁTRICA: REVISÃO SISTEMÁTICA
Bussaglia, M. E. F., da Cruz, M. M., Wiezel, G., Luiz, T. A., Coura, M. H. F., & Gomes, É. L. D. F. D. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.29
ÓXIDO NÍTRICO COMO TRATAMENTO DA HIPERTENSÃO PULMONAR EM NEONATOS
JUELG, R. D. C. L., Myllena, P., Ikeda, P., Resende, V. C., & Kyosen, S. O. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.22
SAÚDE OCULAR DOS ESTUDANTES DE MEDICINA DA UNINOVE EM TEMPOS DE PANDEMIA COVID-19
Soares, A. L. V., da Silva, A. M. A., & Malerbi, F. K. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.18
PRADO, N. G., Grigorini, F. V., & Martorelli, J. F. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.14
Stuchi, A. M., de Matos, L. P., Atum, A. L. B., & Silva, J. A. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.9
EXPRESSÃO MIOCÁRDICA RELACIONADA À CINÉTICA DO CÁLCIO EM ANIMAIS COM EXPOSIÇÃO PRÉ-NATAL AO ÁLCOOL
Resende, A. F. M., Nasuk, G. R., de Jesus, B. C., Atum, A. L. B., & Silva, J. A. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.16
FLUXOGRAMA DE ATENDIMENTO A MULHER VÍTIMA DE VIOLÊNCIA SEXUAL
Santos, K. D. S., Clemente, A. J. M., Moreira, L. K., Morilla, T. C., Gomes, T., & Miziara, C. S. M. G. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.11
O PAPEL DO MICROBIOMA NO DESENVOLVIMENTO DO CÂNCER DE MAMA: UMA ASSOCIAÇÃO POSSÍVEL?
Alencar, A. N. M., Sonoda, R. D. B., Rozenowicz, R. D. L., Marinheiro, J. C., & Rosa, H. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.23
RELAÇÃO DO POTENCIAL ANALGÉSICO DA BETA - ENDORFINA COMPARADA COM O USO DE OPIÓIDES
Arruda, T. H., Zaia, L. F., & Jorge, R. O. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.27
VUONO, B. D. D. D., Pondé, M. C. V., da Costa, B. A. A., & DEZOTTI, J. H. C. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.1
ANÁLISE DOS FATORES DE RISCO PARA DOENÇA RENAL CRÔNICA DURANTE A PANDEMIA DE COVID-19
Martins, A. P., Rezende, G. B. E., Paduam, V., Zanco, L. A. M., Dalboni, M. A., & Pereira, B. J. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.17
FLUXOGRAMA DE ATENDIMENTO À CRIANÇA E ADOLESCENTE VÍTIMAS DE VIOLÊNCIA SEXUAL
Moreira, L. K., Clemente, A. J. M., Santos, K. D. S., Morilla, T. C., Gomes, T. M., & Miziara, C. S. M. G. (2022) · Congresso Médico Acadêmico da Universidade Nove de Julho · doi:10.5585/comamedvg.2022.15
Metadata
- Authors
- Groop, P.-H., Thomas, M. C., Moran, J. L., Wadèn, J., Thorn, L. M., Mäkinen, V.-P., Rosengård-Bärlund, M., Saraheimo, M., Hietala, K., Heikkilä, O., & Forsblom, C.
- Affiliations
- Helsinki University Hospital (FI)
- Baker Heart and Diabetes Institute (AU)
- Department of Intensive Care Medicine, The Queen Elizabeth Hospital, Woodville, South Australia, Australia;
- Folkhälsan Institute of Genetics, Folkhälsan Research Center, Biomedicum Helsinki, Helsinki, Finland;
- Corresponding author
- Groop, Per-Henrik
- ORCID
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2009-04-28
- Volume
- 58
- Issue
- 7
- Pages
- 1651-1658
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- PMC
- PMC2699848
- OpenAlex
- W2101457616
- Semantic Scholar
- 8c94474962d440b785728afdfb3a4ed830eedf9d
- Cited by
- 638
- References
- 49
- Citations by year
- 2026: 14 · 2025: 29 · 2024: 30 · 2023: 38 · 2022: 59 · 2021: 43 · 2020: 40 · 2019: 48 · 2018: 55 · 2017: 43 · 2016: 40 · 2015: 41 · 2014: 54 · 2013: 40 · 2012: 23
- FWCI
- 14.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
- Funders
- Wilhelm och Else Stockmanns Stiftelse
- European Commission
- Signe ja Ane Gyllenbergin Säätiö
- Waldemar von Frenckells Stiftelse
- Topics
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 1 diabetes, chronic kidney disease, all-cause mortality, diabetic nephropathy, albuminuria, microalbuminuria, macroalbuminuria, end-stage renal disease, glomerular filtration rate, hyperfiltration, standardized mortality ratio
- MeSH terms
- Adolescent, Adult, Cause of Death, Diabetes Mellitus, Type 1, Diabetic Nephropathies, Female, Finland, Follow-Up Studies, Glomerular Filtration Rate, Humans, Insulin, Male, Middle Aged, Severity of Illness Index, Cohort Studies, Age of Onset, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.